publication venue for
- Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium 2022
- Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint 2019
- Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration 2019
- Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease 2019
- The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies 2018
- Understanding the impact of sex and gender in Alzheimer's disease: A call to action 2018
- An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease 2017
- Defining imaging biomarker cut points for brain aging and Alzheimer's disease 2017
- Atrial fibrillation, cognitive impairment, and neuroimaging 2016
- MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies 2016
- Convergent genetic and expression data implicate immunity in Alzheimer's disease 2015
- Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 2015
- Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging 2014
- Microbleeds in the logopenic variant of primary progressive aphasia 2014
- Focal hemosiderin deposits and β-amyloid load in the ADNI cohort 2013
- Role of biomarkers in studies of presymptomatic Alzheimer's disease 2005
- Preoperative cerebrospinal fluid and plasma markers of inflammation and neurodegeneration predict mortality eight years later in an observational cohort study of postoperative delirium in an older elective arthroplasty population 2022
- Poster: TNF inhibitors for the prevention of Alzheimer’s disease: Preliminary findings from the rheumatoid arthritis medication and memory study (RESIST) 2021
- Validation of a simplified tissue‐to‐reference ratio measurement using SUVR for the assessment of synaptic density alterations in Alzheimer’s disease using [11C]UCB‐J PET 2020